Reaferon-ES is an advanced recombinant cytokine therapy engineered to deliver broad-spectrum antiviral and immunomodulatory activity. Each vial provides 0,5-5 million International Units (MIU) of Interferon Alfa-2b, synthesized via genetic engineering and stabilized with human albumin. This signaling protein mimics endogenous alpha interferons to rapidly trigger intracellular defense mechanisms, effectively blocking foreign viral synthesis, inhibiting abnormal cell proliferation, and activating specialized immune cells like natural killer (NK) cells and T-lymphocytes.
The convenient 5-vial packaging presentation supplies a structured, highly concentrated course of therapy. Delivered as a dry, freeze-dried lyophilized powder, Reaferon-ES maintains optimal protein stability and structural integrity until the moment of active reconstitution.
Key Uses & Target Symptoms
- Hepatitis Management: Suppresses viral load replication in chronic active Hepatitis B and Hepatitis C therapies.
- Immunomodulatory Support: Restores healthy cellular immune responses in patients dealing with severe secondary immunodeficiencies.
- Antiviral Defense: Treats acute and recurrent systemic or localized viral conditions by halting viral cell reproduction pathways.
- Oncology & Hematology Co-Therapy: Included in specialized clinical protocols to help inhibit malignant cell proliferation in certain hematological and skin conditions.
Main Benefits
- High Biological Purity: Manufactured using advanced recombinant DNA technologies, eliminating risks associated with human donor blood pathogens.
- Stable Lyophilized Form: The freeze-dried preparation guarantees peak active molecule shelf-life and clinical potency when properly stored.
- Multi-Route Flexibility: Designed to support multiple clinical administration methods, including intramuscular, subcutaneous, and targeted local applications depending on the treatment plan.
How to Use
- Reconstitution Process: Carefully dissolve the dry lyophilized powder directly inside the vial using 1–2 ml of sterile water for injection or sterile 0.9% physiological saline solution. Gently agitate the vial until a completely clear, transparent, and particle-free fluid forms.
- Administration Methods: Administer intramuscularly (i.m.), subcutaneously (s.c.), or topically/locally as directed by an individual therapeutic protocol.
- Standard Dosage: For typical acute or chronic viral courses, common regimens range from 1 to 3 MIU daily or three times per week.
